Deerfield Management Company, L.P. (Series C) Dynavax Technologies Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 5,191,493 shares of DVAX stock, worth $53.4 Million. This represents 1.7% of its overall portfolio holdings.
Number of Shares
5,191,493
Previous 5,193,823
0.04%
Holding current value
$53.4 Million
Previous $66.3 Million
1.52%
% of portfolio
1.7%
Previous 1.64%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
311Shares Held
129MCall Options Held
493KPut Options Held
269K-
Black Rock Inc. New York, NY21.9MShares$225 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$183 Million8.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.7MShares$89.4 Million0.0% of portfolio
-
State Street Corp Boston, MA6.79MShares$69.8 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.75MShares$59.1 Million4.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.3B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...